EYA4
Protein phosphatase EYA4
Also known as: CMD1J, DFNA10, EYA4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95677
- Gene
- EYA4
- Ensembl
- ENSG00000112319
- Chromosome
- 6
- Canonical length
- 639 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may act as a transcriptional activator through its protein phosphatase activity, and it may be important for eye development, and for continued function of the mature organ of Corti. Mutations in this gene are associated with postlingual, progressive, autosomal dominant hearing loss at the deafness, autosomal dominant non-syndromic sensorineural 10 locus. The encoded protein is also a putative oncogene that mediates DNA repair, apoptosis, and innate immunity following DNA damage, cellular damage, and viral attack. Defects in this gene are also associated with dilated cardiomyopathy 1J. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
639 residues, UniProt reviewed canonical sequence.
>O95677|EYA4
1 MEDSQDLNEQ SVKKTCTESD VSQSQNSRSM EMQDLASPHT LVGGGDTPGS SKLEKSNLSS
61 TSVTTNGTGG ENMTVLNTAD WLLSCNTPSS ATMSLLAVKT EPLNSSETTA TTGDGALDTF
121 TGSVITSSGY SPRSAHQYSP QLYPSKPYPH ILSTPAAQTM SAYAGQTQYS GMQQPAVYTA
181 YSQTGQPYSL PTYDLGVMLP AIKTESGLSQ TQSPLQSGCL SYSPGFSTPQ PGQTPYSYQM
241 PGSSFAPSST IYANNSVSNS TNFSGSQQDY PSYTAFGQNQ YAQYYSASTY GAYMTSNNTA
301 DGTPSSTSTY QLQESLPGLT NQPGEFDTMQ SPSTPIKDLD ERTCRSSGSK SRGRGRKNNP
361 SPPPDSDLER VFVWDLDETI IVFHSLLTGS YAQKYGKDPP MAVTLGLRME EMIFNLADTH
421 LFFNDLEECD QVHIDDVSSD DNGQDLSTYS FATDGFHAAA SSANLCLPTG VRGGVDWMRK
481 LAFRYRRVKE LYNTYKNNVG GLLGPAKRDA WLQLRAEIEG LTDSWLTNAL KSLSIISTRS
541 NCINVLVTTT QLIPALAKVL LYSLGGAFPI ENIYSATKIG KESCFERIMQ RFGRKVVYVV
601 IGDGVEEEQA AKKHNMPFWR ISSHSDLLAL HQALELEYLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EYA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 29 nTPM
- tongue: 19 nTPM
- seminal vesicle: 9 nTPM
- fallopian tube: 6.2 nTPM
- heart muscle: 5.4 nTPM
- thymus: 5 nTPM
Single-cell type
- pituitary stem cells: 1,751 nCPM
- myonuclei: 1,095 nCPM
- ependymal cells: 821 nCPM
- renal collecting duct principal cells: 717 nCPM
- medullary thymic epithelial cells: 523 nCPM
- choroid plexus epithelial cells: 475 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 23 nTPM
- midbrain: 14 nTPM
- medulla oblongata: 11 nTPM
- white matter: 8.7 nTPM
- spinal cord: 8.4 nTPM
- thalamus: 6.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EYA4.
Disease | AllUniProt
Conditions EYA4 is implicated in, by any mechanism.
- Deafness, autosomal dominant, 10 (DFNA10) MIM:601316
- Cardiomyopathy, dilated, 1J (CMD1J) MIM:605362
Disease | GeneticClinVar
87 pathogenic / likely-pathogenic of 1,228 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Dilated cardiomyopathy 1J
- Autosomal dominant nonsyndromic hearing loss 10
- Cardiovascular phenotype
- Rare genetic deafness
- EYA4-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- cell differentiation
- chromatin organization
- DNA repair
- inner ear development
- negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- positive regulation of DNA repair
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EYA4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EYA4 as an antibody target. Whether an autoantibody or antibody against EYA4 could matter depends on whether native EYA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EYA4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EYA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...